(Q29618061)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

1 reference

1 reference

Weigelt B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

Peterse JL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

van 't Veer LJ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

August 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

page(s)

591-602

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

Gene expression profiling predicts clinical outcome of breast cancer

30 April 2017

cites work

1 reference

A gene-expression signature as a predictor of survival in breast cancer

1 May 2017

1 reference

A molecular signature of metastasis in primary solid tumors

1 May 2017

1 reference

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

1 May 2017

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 May 2017

1 reference

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 May 2017

1 reference

Prospective identification of tumorigenic breast cancer cells

1 May 2017

1 reference

Molecular portraits of human breast tumours

1 May 2017

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 May 2017

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 May 2017

1 reference

New functions for the matrix metalloproteinases in cancer progression

1 May 2017

1 reference

Evaluation of gene expression measurements from commercial microarray platforms

1 May 2017

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 May 2017

1 reference

A DNA-Binding Protein Helps Repair Breaks in DNA Double Helix

1 May 2017

1 reference

Putting tumours in context

1 May 2017

1 reference

Stromal fibroblasts in cancer initiation and progression

1 May 2017

1 reference

Stem cells, cancer, and cancer stem cells

1 May 2017

1 reference

Identification of human brain tumour initiating cells

1 May 2017

1 reference

Computational analysis of microarray data

1 May 2017

1 reference

Cluster analysis and display of genome-wide expression patterns

1 May 2017

1 reference

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 May 2017

1 reference

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 May 2017

1 reference

Metastasis results from preexisting variant cells within a malignant tumor

31 March 2020

1 reference

Spontaneous metastasis: random or selective?

31 March 2020

1 reference

Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours

31 March 2020

1 reference

Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma

31 March 2020

1 reference

31 March 2020

1 reference

Breast carcinoma: Pattern of metastasis at autopsy

31 March 2020

1 reference

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination

31 March 2020

1 reference

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

31 March 2020

1 reference

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

31 March 2020

1 reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

31 March 2020

1 reference

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up

31 March 2020

1 reference

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

31 March 2020

1 reference

Karnofsky Memorial Lecture. Natural history of small breast cancers

31 March 2020

1 reference

Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.

31 March 2020

1 reference

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

31 March 2020

1 reference

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

31 March 2020

1 reference

Bias as a threat to the validity of cancer molecular-marker research

31 March 2020

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

31 March 2020

1 reference

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

31 March 2020

1 reference

Targeted therapy in breast cancer: the HER-2/neu gene and protein

31 March 2020

1 reference

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

31 March 2020

1 reference

Circulating tumour cells in breast cancer

31 March 2020

1 reference

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance

31 March 2020

1 reference

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

31 March 2020

1 reference

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status

31 March 2020

1 reference

Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

31 March 2020

1 reference

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

31 March 2020

1 reference

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

31 March 2020

1 reference

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

31 March 2020

1 reference

Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR

31 March 2020

1 reference

Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated

31 March 2020

1 reference

Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients

31 March 2020

1 reference

Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties

31 March 2020

1 reference

A putative human breast stem cell population is enriched for steroid receptor-positive cells

31 March 2020

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: A review

31 March 2020

1 reference

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

31 March 2020

1 reference

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

31 March 2020

1 reference

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

31 March 2020

1 reference

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

31 March 2020

1 reference

Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination

31 March 2020

1 reference

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

31 March 2020

1 reference

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

31 March 2020

1 reference

A big trial for a new technology: TransBIG Project takes microarrays into clinical trials

31 March 2020

1 reference

Gene expression predictors of breast cancer outcomes

31 March 2020

1 reference

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

31 March 2020

1 reference

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

31 March 2020

1 reference

A multigenic program mediating breast cancer metastasis to bone

31 March 2020

1 reference

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

31 March 2020

1 reference

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

31 March 2020

1 reference

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

31 March 2020

1 reference

Outcome signature genes in breast cancer: is there a unique set?

31 March 2020

1 reference

Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma

31 March 2020

1 reference

Metastasizing potentials of mouse mammary tumors and their metastases

31 March 2020

1 reference

Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours

31 March 2020

1 reference

Do metastases arise from pre-existing subpopulations of cancer cells?

31 March 2020

1 reference

Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells

31 March 2020

1 reference

Quantitative genetic analysis of tumor progression

31 March 2020

1 reference

Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection

31 March 2020

1 reference

Functionality of circulating DNA: the hypothesis of genometastasis

31 March 2020

1 reference

Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17.

31 March 2020

1 reference

Gene expression profiles of primary breast tumors maintained in distant metastases

31 March 2020

1 reference

Gene expression profiles of human breast cancer progression

31 March 2020

1 reference

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

31 March 2020

1 reference

Breast cancer, stem/progenitor cells and the estrogen receptor

31 March 2020

1 reference

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

31 March 2020

1 reference

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

31 March 2020

1 reference

Self-renewal and solid tumor stem cells

31 March 2020

1 reference

31 March 2020

Road map to metastasis

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Selection of Successive Tumour Lines for Metastasis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1033699583

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16056258

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017